Functional hepatic flow can predict the hepatic reserve function in surgical cirrhotic patients

Wu Xingjiang1, Ding Weiwei, Cao Jianmin

  • 1Research Institute of General Surgery, School of Medicine, Nanjing University, Jinling Hospital, Nanjing, Jiangsu Province, China. wuxingjiang@gmail.com

Insights

Monitoring functional hepatic flow (FHF) in cirrhotic patients helps predict hepatic reserve function after surgical treatments. FHF changes vary significantly based on specific surgical interventions like TIPS.

Area of Science:

  • Hepatology
  • Surgical Gastroenterology
  • Medical Imaging

Background:

  • Cirrhosis significantly impacts hepatic reserve function.
  • Portal hypertension is a common complication in cirrhotic patients.
  • Surgical interventions aim to manage complications of portal hypertension.

Purpose of the Study:

  • To evaluate hepatic reserve function in cirrhotic patients undergoing surgery.
  • To monitor functional hepatic flow (FHF) as an indicator of hepatic reserve.
  • To correlate FHF changes with different surgical treatments for portal hypertension.

Main Methods:

  • Thirty-seven cirrhotic patients (Child-Pugh A, B, C) and 10 healthy volunteers were studied.
  • Patients underwent various surgical procedures including Transjugular Intrahepatic Portosystemic Shunt (TIPS) and portal-azygous disconnection.
  • Functional hepatic flow (FHF) and total hepatic flow (THF) were measured using D-sorbitol clearance and Doppler sonography; portal pressure was catheterized.

Main Results:

  • Cirrhotic patients exhibited reduced FHF and increased portal blood flow, hepatic artery flow, and THF compared to controls.
  • Portal pressure and FHF decreased post-TIPS and after combined TIPS/disconnection or disconnection/shunt procedures.
  • FHF showed a significant decrease in patients treated with TIPS compared to other surgical groups.

Conclusions:

  • Monitoring FHF is valuable for predicting hepatic reserve function in cirrhotic patients.
  • Different surgical operations result in distinct changes in FHF.
  • FHF monitoring can guide clinical decisions for surgical management of cirrhotic patients.
Abstract

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance01:09

Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance

Hepatic clearance refers to the volume of blood cleared of a drug by the liver per unit of time. It plays a crucial role in drug metabolism and elimination. While hepatic clearance is commonly estimated by subtracting renal clearance from total body clearance, other pathways, such as pulmonary or biliary clearance, may also contribute. However, these pathways are generally less significant than hepatic and renal clearance.
Most drugs undergo restrictive clearance, which is proportional to the...
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug01:14

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...